Buzz Pocket

Friday, April 30, 2021

Top Scenario: Medical Nonwoven Disposables Market Revenue, Growth Rates, and Industry Challenges in 2020-2027

The global medical nonwoven disposables market is predicted to observe a significant growth in forecast period due to the growing SSI and HAI infections across the globe. The North America region is expected to grow enormously by 2027.

As per a Research Dive report, the global nonwoven disposables market is expected to witness a considerable growth and is predicted to generate a significant revenue during the forecast period from 2020 to 2027. The North America medical nonwoven disposables market is projected to hold a dominant position throughout the forecast period, majorly attributed to huge geriatric population in the region that choose medical nonwoven disposables owing to its convenience and security.ADVERTISEMENT

Market Dynamics

The increasing occurrence of surgical site infections (SSIs) and the rising number of HAI patients across the globe are the significant factors predicted to fuel the growth of the global medical nonwoven disposables market in the forecast period. In addition, the growing awareness amongst patients related to the preventive steps needed to be taken from various forms of infections is another factor projected to bolster the market growth by 2027. Moreover, technological advancements and rapid innovations in medical nonwoven disposables are likely to create huge opportunities for the growth of the global market. Conversely, the easy availability of alternatives such as reusable gowns, drapes, surgical masks, trouser shields, and reusable undergarments is expected to hinder the market growth in the projected timeframe.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/365

Key Segment Takeaways of the Market:

The report segments the global medical nonwoven disposables market into Product, Application, End-users, and Region.

By product, the global market is bifurcated into surgical nonwoven products and incontinence hygiene products. Of these, the surgical nonwoven products segment is predicted to lead the market over the forecast period, as the materials used in surgical nonwoven products prevents surgical site infections.

By application, the overall market is categorized into online platforms, hospital pharmacies, and retail pharmacies. Of these, the hospital pharmacies segment is projected to lead the global market in terms of revenue share mainly because of the link of hospital pharmacies with nonwoven disposables distributors.ADVERTISEMENT

By end-users, the global market is classified into nursing homes, hospitals, clinics, consumer home healthcare, and ASCs. Among these, the ASCs segment is estimated to subjugate in terms of market share, owing to the rising demand for nonwoven medical disposable products for various surgical procedures.

Geographically, the overall industry is divided into Asia Pacific, North America, LAMEA, and Europe. The Asia Pacific region is expected to grow at the fastest rate by 2027, owing to the reduced incidence and growing awareness regarding HAI infections in the region.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/365

Prominent Market Players

The major players of the global medical nonwoven disposables market are Medtronic, Domtar, Kimberly Clark, Asahi Kasei Corp., MRK Healthcare, Mlnlycke Health Care, Unicharm Corp., Ontex Group, First Quality Enterprises Inc., and Cypress Medical Products LLC. Further, the report outlines several aspects of all these industry players such as SWOT analysis, recent strategic moves developments, financial performance, and product portfolio.

These players are emphasizing more on mergers, acquisitions, and advanced product developments to obtain a strong position in the global industry. For instance, in January 2019, MONIT Corporation created a cookie-sized sensor, Smart Diaper which is enabled with Bluetooth technology. Smart Diaper helps parents to keep a track of the bowel movements of the baby and helps in preventing from urinary tract infections and diaper rash.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Industry Verticals: Energy-based Cancer Treatment Market by Key Vendors, Challenges and Opportunities 2027

The rising usage of energy-based treatment methods in cancer treatments is fueling the global energy-based cancer treatment market growth. The Asia Pacific region is likely to unlock rewarding opportunities during the forecast period.

Research Dive has added a new report to its offering titled, Energy-based Cancer Treatment Market, by Treatment Type (Invasive, Non-invasive), Source of Energy (Proton Beam, X-Rays, Electron Beam, Gamma Rays), Application (Breast Cancer, Cervical Cancer, Prostate Cancer, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 20192026.ADVERTISEMENT

The report claims that the global energy-based cancer treatment industry is projected to observe notable growth from 2019 to 2026. This research report offers comprehensive insights on the present condition and future outlook of the market. The report is an inclusive research study, delivering consistent market insights for new entrants, shareholders, established market players, investors, stakeholders, etc.

Key Segment Highlights of the Market:

The market is segmented based on type, application, source of energy, and region.

Among type segment, the non-invasive treatment type sub-segment is expected to perceive substantial growth in the projected timeframe. This is mainly because of the efficiency of non-invasive treatment type of the energy-based cancer treatment in detecting the accurate position of the cancer cells and destroying them without harming healthy cells.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/105

Among application segment, the breast cancer application sub-segment is projected to witness extraordinary growth and grab a major share of the market share in the estimated period. This is mostly due to growing widespread use of energy-based cancer treatment systems for the treatment of breast cancer worldwide, as breast cancer is the most common cancer related disease amongst females.

Based on region, the Asia Pacific region market is estimated to experience speedy growth and bring in rewarding growth opportunities for the market growth in the forecast period. This is mainly due to the rising cases of cancer disorders and increasing government programs on control of cancer disease and cancer awareness in the Asia-Pacific region in the region.

Market Dynamics

As per the report, the growing cases of cancer disorders worldwide and rising usage of energy-based treatment methods in cancer treatments are the major factors boosting the global energy-based cancer treatment industry growth. In addition, rising government initiatives for cancer awareness and treatment is contributing to the growth of the market. Furthermore, increase in the developments in the cancer treatment methods are expected to create novel opportunities for the market growth in the coming years.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/105

Top Players of the Industry

The key players of the global energy-based cancer treatment industry are Siemens Healthcare Private Limited, Accuray Incorporated, NTP Radioisotopes SOC Ltd., Mevion Medical Systems, IBA Worldwide, Hitachi, Ltd., Isoray Inc., Elekta AB (pub), ProTom International, RANOR, Inc., and others.

Numerous winning business approaches and plans, including groundbreaking technological advances, RD activities, acquisitions and mergers, etc., carried out by these players are aiding them in achieving a noteworthy position in the global market. For instance, in September 2020, EDAP TMS SA, a leading player in robotic energy-based therapies, have declared that it will host a major opinion leader (KOL) call on its two main commercial products, ExactVu and Focal One.

In addition, the report provides several finer points about the leading players, such as annual performance, financial status, and product portfolio along with Porter Five analysis and SWOT analysis.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Development Trends: Automated Analyzer Market - Future Growth, Verticals, Segmentation & Forecast to 2027

The automated analyzer market is predicted to observe remarkable growth in the upcoming years. The growing advances in the automation technologies and rising demand for automated analyzer across the globe is boosting the growth of the market. The immuno based analyzer type sub-segment and clinical analysis application sub-segment are projected to experience significant growth in the projected period. The Asia Pacific market is expected to reveal profitable opportunities in the near future.

Research Dive has added a new report to its repository on the global automated analyzer market. As per the report, the market is projected to witness stupendous growth from 2020 to 2027. This research report provides all-inclusive insights on the present condition and future perspective of the market. The report is a complete research study, providing reliable market insights for new market players, shareholders, proven market players, investors, stakeholders, etc.ADVERTISEMENT

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/98

Factors Impacting the Market Growth

According to the report, the rising need for digitalization of the regular clinical, medical, and chemical laboratory practices by implementing Internet of Things (IoT) is the major factor thriving the growth of the global automated analyzer industry. Furthermore, the growing demand for cohesive healthcare systems and compulsion by the governments as well as end users for the implementation of automation technologies to the existing systems for serving more patients in the less period of time and avoiding the human errors in the diagnosis are likely to increase the demand for automated analyzers. In addition, growing advances in the automation technologies is expected to reveal novel investment opportunities for the growth of the global market.

The report segments the global automated analyzer market into type, application, end user, and region.

Immuno Based Analyzer Type Sub-Segment to Grow Rapidly in the Forecast Period

Among type segment, the immuno based analyzer type sub-segment is anticipated to experience fast-paced growth during the forecast period. This is mostly because analyzers are gaining more and more popularity and importance as a tool to detect proteins in medical laboratories.ADVERTISEMENT

Clinical Analysis Application Sub-Segment to Witness Remarkable Growth in the Forecast Period

Among application segment, the clinical analysis application sub-segment is expected to witness remarkable growth and grab a major share of the market size during the forecast period. This is mainly due to the widespread utilization of automated analyzers in the medical pathology for the diagnosis of body fluids, which is useful in therapeutics and analysis of various diseases.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/request-toc-and-sample/98

Asia-Pacific Region to Unlock Rewarding Investment Opportunities in the Forecast Period

The report evaluates the global automated analyzer market across several regions including Asia Pacific, North America, Europe, and LAMEA. Among these, the Asia-Pacific region is projected to witness speedy growth during the forecast period. This is mostly due to rising cases of blood disorders, increasing importance and awareness about health care, and presence of huge number of pharmaceutical companies in the region.

Top Players in the Market

The key players stated in the report are Erba Mannheim, Thermo Fisher Scientific Inc., Danaher, F. Hoffmann-La Roche Ltd., Siemens, Ortho Clinical Diagnostics, ELITechGroup, BD, Hudson Robotics, HORIBA, Ltd., and others.

The report offers several business strategies and approaches implemented by these players. For instance, in September 2020, LexaGene, a molecular diagnostics firm, has invented a gold standard diagnostic instrument named MiQLab that uses a proprietary RT-qPCR-based method to evaluate every samples contents for nearly 27 different pathogens in roughly one hour.

Moreover, in the same month, researchers from ACS Analytical Chemistry have invented a completely automated microchip electrophoresis analyzer that can aid in the detection of signs of extraterrestrial life. Furthermore, the report offers insights such as company overview performance, product/service line, and SWOT analysis of the foremost players functioning in the global automated analyzer industry.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Thursday, April 29, 2021

Competitive Scenario: Breast Implant Market Revenue, Growth Rates, and Industry Challenges in 2027

Breast Implant Market size will exceed $4.9 Billion by 2026, growing at a CAGR of over 10.3% from 2019 to 2026; according to a new research study by Research Dive.

An increase in the number of breast augmentation processes, along with the rise in breast cancer incidences across the world will significantly drive the global breast implant market size over the forecast period. The breast augmentation processes enable women to improve their breast size, and also to improve their hip contour balance. These are also called as reconstruction procedures, which help to restore the breasts size to near normal size. They also help in improving the appearance of the breasts. Rapid growth in these procedures will significantly spur the global breast implant market growth during the projected timeline.ADVERTISEMENT

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/41

Rapid growth in the incidences of breast cancer across the world will boost the growth of breast implant market growth in the coming years. As a result of this, the majority women are preferring mastectomy procedures during their breast cancer treatment.

However, the high cost of implantation procedures, coupled with the rising implications post-surgeries will impede the breast implant market growth.

The silicone breast implant market size held the largest share in 2018 and is projected to grow at a CAGR of over 10.2% over the projected timeframe. The dominant market size is expected throughout the forecast period, owing to the products capability to look natural. Some of the other benefits such as reduced wrinkling will further provide a significant boost to product adoption.

The breast implant market for reconstruction procedure will increase at a CAGR of more than 10.7% during the projected period. This is majorly due to the increasing incidences of breast cancer, and also to avoid them. An increase in awareness about reconstruction surgery to overcome the cancer incidences has resulted in significant growth in procedure adoption.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/41ADVERTISEMENT

The majority of the patients are preferring clinics as their place of surgery. This is majorly due to the presence of skilled professionals, coupled with the less cost associated with the comparison with the hospital sector. Breast implant procedures in clinics will grow at a CAGR of over 9.8% during the projected period. Expanding infrastructure in the healthcare sector in the emerging economies will further enhance the market growth. This segment will further grow on account of the availability of skilled plastic surgeons in the clinics.

North America market held a significant market share in 2018 and accounted for more than 40% in 2018. An increase in the number of the female population preferring the augmentation procedures will further drive the market growth. Growth in per capita expenditure, coupled with the rise in disposable income will further serve to be one of the high impacting factors for the growth of North America breast implant market growth.

The Asia-Pacific market is projected to witness a robust growth at 11.0% CAGR during the forecast period. The rise in the number of hospitals and clinics offering plastic surgery procedures, coupled with the increase in the number of plastic surgeons in this region will enhance the regional market growth during the coming years.

Some of the prominent companies in the global breast implant market includeGC Aesthetics, Allergan, Mentor Worldwide LLC, Laboratoires Arion, Groupe Sebbin, Hansbiomed Co. Ltd., Sientra Inc., Silimed, Groupe Sebbin SAS, and CEREPLAS among many others. Some of the strategies preferred by the operating companies are product development and acquisitions.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Growth Outlook: Activated Partial Thromboplastin Time Test Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2027

The global activated partial thromboplastin time test market forecast will surpass $601.2 million by the end of 2026, at a CAGR of 6.8%, and has been rising from $353.0 million in 2018, according to Activated Partial Thromboplastin Time Test Market Analysis by Research Dive.

Activated Partial Thromboplastin Time Test Market Trends: Rise in the prevalence of cardiovascular diseases coupled with increase in the demand for thromboplastin test instruments the key drivers for the growth of the activated partial thromboplastin time test market. Increase in the adoption of thromboplastin test in the point-of-care diagnostic centers and improvements in the healthcare infrastructure are projected to drive the market growth. The improvements in healthcare infrastructure support the accessibility of test instruments and easy available of coagulation testing devices is anticipated to boost the activated partial thromboplastin time (APTT) test market growth. Furthermore, there is a rise in the blood disorders with increasing age of people across the globe; they require regular blood check-up to determine common and intrinsic pathways of blood coagulation. Due to wide usage of APTT test devices, the market is projected to grow in the coming years. Price of the treatment test coupled with dearth of skilled personal to perform APTT test are expected to hinder the growth of the market. Technological improvements in the activated partial thromboplastin time (APTT) testing instruments and key manufacturers concentrating on mergers acquisitions to minimize the devices cost is anticipated to create ample investment opportunities in the activated partial thromboplastin time test market.ADVERTISEMENThttps://e54a0f5716ab43bbb48be0c473f5cfd9.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/79

Instruments type segment will witness a noteworthy growth during the projected time. The growth is majorly because companies are increasing the RD activities on diagnostic instruments to improve performance and accuracy of the instruments with low cost. The activated partial thromboplastin time test market for instruments product type is estimated to account for $289.8 million by 2026 at a 7.2% CAGR.

The market for point-of-care testing is projected to experience significant growth; it is anticipated to generate a revenue of $83.6 million by 2026 and is growing at a 7.7% CAGR. This growth is because of an increase in the number of point-of-care testing centers along with an increase in the population with age group above 60. The hospitals segment held the largest activated partial thromboplastin time test market size in 2018; it is estimated to reach $217.6 million by 2026, increasing at a growth rate of 6.5%. This is because of the growing usage of thromboplastin time test devices in the hospitals sector to treat patients for the analysis of hematological.ADVERTISEMENT

Asia-Pacific market will witness the highest growth rate of 7.3% CAGR and is expected to register a revenue of $143.1 million by 2026. This growth is attributed to swift progress in healthcare along with people preferring the point of care diagnosis of hospitals. Due to this swift growth, the Asia-Pacific market is predicted to grow during the forecast time. The global activated partial thromboplastin time test market was dominated by Europe, it was registered for majority of the activated partial thromboplastin market share, which was 30.0% in 2018. This growth is owing to the presence of upgraded diagnostic infrastructure in Europe. The market for North America region is expected to generate a revenue of $156.3 million by the end of 2026 with a CAGR of 6.7% during the projected time period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/79

Top gaining participants in the activated partial thromboplastin time test market are Bio-Rad Laboratories, Inc., ThermoFisher, Abbott, bioMrieux, Inc., Danaher, Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Takara Bio Inc., HORIBA, Ltd., Ortho Clinical Diagnostics and Siemens Healthcare Private Limited. These participants are continuously increasing their efforts to improve the product performance and introducing new technologies to gain the largest market share in the overall activated partial thromboplastin time test industry.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Top Scenario: Airway Management Devices Market by Key Vendors, Challenges and Opportunities 2027

According to a study by Research Dive, the global Airway Management Devices Market forecast size is expected to reach $2,178.8 million by the end of 2026, registering a 7.4% CAGR over the forecast period.

Growing occurrence of chronic obstructive pulmonary disease (COPD), predominantly respiratory diseases, along with growing necessity for emergency care, will upsurge the global market. According to the data published by WHO in November 2016 the Global Burden of Disease Study, around 251 million cases of COPD were registered globally and main causes for their occurrences were long-term asthma, active smoking, and growing indoor air pollution. Moreover, chronic obstructive pulmonary disease incidences are anticipated to grow over the forecast period due to the rise in the aged population and growth in the people smoking globally.ADVERTISEMENT

Rising number of patients suffering with respiratory issues in ICUs is further expected to drive the necessity for airway management devices over the forecast period. Patients needing anesthesia before the surgical procedures require constant use of ventilators; this is one of the key factors that is projected to drive the market growth in the recent years. Nevertheless, lack of skilled professionals and harmful effects of ventilator devices on pediatric patients will hamper the airway management devices market growth over the projected timeframe.

Click Here to Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/81

Infraglottic airway devices segment by type is expected to dominate global airway management devices industry accounting for 662.4 million in 2026, growing at a CAGR of 6.4%. The growth is majorly attributed to the growing demand of infraglottic devices in emergency care units along with growing number of aged population globally. In addition, rising consciousness of respiratory diseases is further expected to create lucrative growth opportunities for the manufacturers across the globe. Supraglottic airway management devices sub-segment is expected to register a lucrative growth over the forecast period registering a CAGR of 8.3% over the forecast period. This is majorly due to the high rate of success in interactive airway block cases coupled with less complications that are involved.ADVERTISEMENT

Operating rooms segment accounted for the highest airway management devices market share of 38.90% in 2018, valued at $478.8 million. This is majorly due to the substantial growth in the number of operating procedures along with rising incidences of chronic respiratory diseases. Moreover, health experts are following more effective safety procedures which is expected to drive the market over the projected period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/81

North America airway management devices market size was $504.6 million in 2018 and held the largest market share which was 41%. This region is further expected to continue its dominance over the forecast period due to increasing number of pediatric patients suffering from various lung diseases coupled with rising necessity of airway management devices. Asia-Pacific region is anticipated to register a substantial growth over the forecast period, growing at a CAGR of 7.8%, accounting for $359.5 million in the year 2026. This growth is majorly driven due to the growing adoption of airway management devices across the various developing nations in this region, such as India, China and South Korea.

The key players in airway management devices market areSmiths Medical, Intersurgical Ltd., Medtronic, Teleflex, SunMed, Ambu A/S, Flexicare Medical Limited, KARL STORZ SE Co. KG, Vyaire Medical Inc. and VBM Medizintechnik.These key players are majorly concentrating on merger acquisitions, partnerships, and new product development among others, to strengthen their presence across the globe. In October 2017, Smiths Medical announced the launch of three new devices for ambulatory infusion, airway management, and blood pressure monitoring. The airway management system namely aerFree is FDA cleared exterior negative air pressure support.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Industry Verticals: Coagulation Testing Market by Key Driver, Challenges and Opportunities 2027

As per the study of Research Dive, coagulation testing market forecast a revenue of $3,566.0 million in the year 2026 growing at healthy CAGR of 5.9%.

Coagulation test is primarily carried out by a coagulometer that detects blood clotting time and bloods ability to clot. Consistent technological advancements in coagulation testing devices is driving the growth of the market. The growing prevalence of various blood clotting disorders, such as deep vein thrombosis (DVT), and hemophilia along with rise in aging population across the globe are the significant growth factors for the coagulation testing market. On the other hand, factors such as lack of expertise in this filed and higher costs of coagulation test devices are expected to obstruct the growth of the coagulation testing industry. Blood clot level plays a crucial role in human body as it helps in treatment of multiple diseases such as stroke, diabetes and others. IoT enabled healthcare devices have the ability of real time monitoring of blood coagulation, which helps to keep the patients activity under the therapeutic range with reduction of risk factor. Key advantage of this device is that it helps the patient to quickly monitor blood clots. It also lowers the risk of bleeding problems of diabetic patients. This IoT enabled application has facility to remind patients to test their clot level, which helps in reduction of risk factors. These coagulation testing market trends are anticipated to create lucrative opportunities for the growth of global coagulation testing industry.ADVERTISEMENT

Click Here to Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/86

Consumable type has the major share in global Coagulation Testing market; it will generate a revenue of $1,847.2 million by the end of 2026, at a CAGR of 5.6% till 2026. Coagulation Testing market size of instruments segment will generate a revenue of $1,718.8 million by 2026, increasing at a CAGR 6.3%. Remarkable advances and vast RD efforts from manufacturers result in improvisation of reliable analyzers. This has been increasing the demand for high precision and advanced coagulation analyzers at a steady pace; these factors are expected to drive the growth of the global market. Furthermore, these analyzers are fully automated, and also can perform immunologic and chromogenic assays. These significant factors are expected to grow the global market.ADVERTISEMENT

Prothrombin time segment has a major share and is expected to generate a revenue of $2,475.7 million by the end of 2026, growing at a CAGR of 5.5%.Clotting time tests such as prothrombin time are majorly performed in hospital setting for perspective reason of hemostatic evaluation for multiple reasons. Moreover, Prothrombin time tests are carried out to assess the risk of thrombosis or bleeding and to monitor response to anticoagulant therapy in patients. These tests are mainly useful to diagnose and treat multiple bleeding and clotting disorders and also used to monitor the efficacy of various anticoagulants. These benefits from prothrombin time tests are estimated to spur the coagulation testing market growth. Thrombin time segment for global market shall cross $392.3 million in 2026, growing at a healthy CAGR 7.3%.

Hospitals segment has a major market share and is expected to generate a revenue of $1,290.9 million by the end of 2026, growing at a CAGR of 5.6%; this is mainly owing to massive demand for comprehensive medical care and vital innovation in therapeutic techniques. In addition, significant patient support along with affordable care for patients are making positive impacts on the growth of global market.

Point-of-Care testing will generate a revenue of $495.7 million by 2026, growing at a CAGR 6.8%. Enhancement in blood coagulation analyzers along with rising number of professionals in the development of POC (point-of-care) devices is projected to boost the growth of global market. Rising popularity for trend of self-monitoring and raised availability of POC devices for hospitals are also anticipated to fuel the demand for global market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/86

Asia-Pacific market will cross $848.7 million in 2026, increasing at a CAGR of 6.4%. The market share of this region is projected to increase at a fast rate because of massive expansion of healthcare centers and hospitals and major patient population. Moreover, market players are focusing more on the innovations in the coagulation tests and devices, for instance, Japan based company, Sysmex launched new Products called Automated Blood Coagulation Analyzers CN-3000 and CN-6000. This device offers enhanced levels of reliability and productivity, in turn responding to various customer needs and advanced quality in the field of hemostasis; these advances in technology are projected to augment the growth of Asian market.

Europe coagulation testing market share is dominant and it is expected to grow at a CAGR of 6.2% by registering a revenue of $1,094.8 million by 2026.

Europe region is focusing more on the recent innovation and excellent strategies are anticipated to drive the European Market growth. Since the past 25 years, the number of CVD (Cardiovascular disease) cases has increased in Europe mainly due to rise in the fat consumption. In addition, levels of obesity are high across Europe in both adults and children. These health issues are projected to augment the growth of market of Europe region.

Some of the leading market players are:Medtronic, Micropoint Biosciences, Helena Laboratories Corporation., Thermo Fisher Scientific Inc., Abbott., F. Hoffmann-La Roche Ltd, BD., NIHON KOHDEN CORPORATION., Sysmex Corporation, and Danaher.Significant coagulation testing companies are initiating various steps in order to strengthen their presence such as merger acquisitions and new product development. For example, Micropoint Bioscience launched Micropoint Bioscience Point of Care Devices in which relatively small blood volume is required for coagulation monitor. To highlight on the competitive landscape analysis of multinational establishments, the porters five force model is discussed in the report.

Top Trending Reports-
Airway Management Devices Market https://www.researchdive.com/81/airway-management-devices-market
Activated Partial Thromboplastin Time Test Market https://www.researchdive.com/79/activated-partial-thromboplastin-time-test-apttt-market
Medical Device Manufacturing Outsourcing Market https://www.researchdive.com/165/medical-device-manufacturing-outsourcing-market

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Development Trends: Private Nursing Services Market by Top Key Players, Applications and Forecast to 2020-2027

According to Research Dive, the global private nursing services market is predicted to grow at a CAGR of 5.7%, and will surpass $1,299.8 billion by 2026

Private nursing services are the services provided to the client as per their requirement and convenience. Private nursing services are run by companies that provide quick access to treatments, choice of when the treatment should commence, along with providing an opportunity to select or change the professional. To avail the services, the client must pay a chargeable fee to the company or the hospital from where the professional has been selected. These services are mostly provided to clients, who have chronic health issues, by giving special attention to the geriatric people and kids and people suffering from serious damages in the outer and inner parts of the bodies.ADVERTISEMENT

Increasing chronic diseases and rise in the number of nuclear families are anticipated to drive the private nursing care services market. At present, people prefer to stay in a nuclear family, and this is the biggest driving factor for the growth of private nursing services. Due to lesser number of family members in the nuclear family, it turns out to be a tough task to take care of the geriatric person in the family. A patient with chronic diseases needs special attention and it becomes difficult for the family members to keep an eye on the patient every time. Thus, it is predicted that the rise in the occurrences of deadly diseases will drive the private nursing services market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/95

The lack of skilled workers is one of the biggest restraints for the private nursing careet services market. The market lacks trained professionals across the globe. According to the World Health Organization (WHO), it was estimated that there was a shortage of 4 million workers in the global health force, which mainly consisted of nurses and community healthcare worker. This mainly arises due to the lack of education, appropriate skill set and experienced professionals, causing a huge impact on the private nursing services market growth.

Depending on the service type, the market is further segmented into nursing care facilities, group care homes, retirement communities, and home healthcare providers.Retirement communities held the largest market share of 25.0% in 2018. The retirement communities segment was $208.6 billion in 2018 and is further projected to grow at a CAGR of 6.8% in the forecast.Increasing geriatric population and an increase in the number of nuclear families are predicted to drive the market for the service type segment in the private nursing services market.ADVERTISEMENT

Depending on the end use, the market is further divided into female nursing care and male nursing care. In 2018, female nursing care segment held the largest market share of 61.0%. Female nursing care is predicted to generate a revenue of $773.4 billion by 2026 with a CAGR of 5.4% in the forecast period. The market is majorly dominated by female nurses because female nurses more often than not are able to provide special care and attention to the patient. Moreover, patients prefer female nurses over male nurse. These factors are estimated to drive the end use segment in the private nursing services.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/95

Depending on the region the market is further segmented into Asia-Pacific, North America, Europe and LAMEA. In 2018, North America held the largest market share of 38.0%. North America is predicted to grow at a CAGR of 5.4% by generating a revenue of $483.5 billion by 2026. Favorable government regulations with regards to healthcare and rise in the geriatric population are predicted to give boost to this region. Asia Pacific accounted for the highest growth across the globe in the forecast period.

Asia-Pacific private nursing services market size is predicted to grow at a CAGR of 6.3% by generating a revenue of $300.2 billion by 2026. The presence of a large population having chronic diseases like blood pressure, asthma and diabetes is predicted to drive the market for the region.

The key players in the private nursing services market areGrand World Elder Care, Apollo Hospitals Enterprise Ltd., Columbia Asia, Trinity Health, CBI Health Group Inc., Kaiser Permanente, Brookdale Senior Living, Genesis Healthcare, Kindred Healthcare, LLC and The Ensign Group, Inc., among others.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Future Growth: Plant-based Biologics Market by Key Driver, Challenges and Opportunities 2027

According to a study of Research Dive, the global plant-based biologics market forecast shall cross $164.2 million by 2026, growing at a CAGR of 6.1%.

Plant-made biologics are produced by molecular farming and they have significant potential as compared to other biologics. For instance, the plant-made experimental antibody called ZMapp can be used against the Ebola virus. Also, in recent times, leading researchers have been focusing more on molecular farming i.e production of animal-free therapeutic proteins such as oral and parenteral vaccines. These factors are projected to drive the growth of the global plant-based biologics market. Moreover, advancements in plant biotechnology are one of the major factors for the positive growth of the global plant-based biologics market, during the forecast period.ADVERTISEMENT

In addition, mAbs (Monoclonal antibodies) in plants have several desirable attributes such as they have relatively low cost and require short production time. Furthermore, plant-derived mAbs are mainly biodefense agents that rapidly respond to a newly emergent/re-emergent disease or bioterror event. However, intense scrutiny of new plant varieties by public and regulatory agencies along with the higher costs associated with their regulatory approval are projected to restrain the demand for plant-based biologics in the global market. Contrary to this, the tobacco plant is considered as the ideal host for bioengineered proteins because itgrows quickly and gives high yield production.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/150

Tobacco leaves can produce high amount of antibodies within 6-7 days. Also, Nicotiana benthamiana species is used for the production of pandemic and seasonal flu vaccines. Market players such as PlantForm, are preferring the tobacco plant to produce a breast cancer drug which is similar to Herceptin. Furthermore, researchers are focusing more to develop an H1N1 flu vaccine and malaria vaccine by using Tobacco-based biologics. These, huge developments in tobacco-made biologics are further anticipated to create enormous opportunities for the plant-based biologics.

The leaf-based biologics segment will generate a revenue of $71.0 million by the end of 2026, growing at a CAGR of 5.6%, over the projected period.Leaves have huge potential as photosynthetic factories for the production of commercially valuable biomedicines and crucial industrial proteins at a lower cost. Recently, it has been proved that there are several health benefits of vine leaves such as they show 10 times higher antioxidant activity than pulp or grape juice. These key elements are anticipated todrive the growth of this market.ADVERTISEMENT

The global duckweed-based biologics market has a significant market share, and it shall generate a revenue of $12.0 million by 2026, rising at a CAGR of 11.2%,over the forecast period. Duckweed is known to be a convenient and simple host for the study of the pathogenic bacterial infection. In addition, duckweed is identified as a crucial tool in the large-scale screening for the invention of new antimicrobial products. The tobacco-based biologics is the fastest-growing segment, and it shall register a revenue of $71.0 million by 2026, growing at a CAGR of 5.6%, during the forecast period.

The Europe plant-based biologics market shall surpass $51.5 million by 2026, growing at a healthy CAGR of 8.1%. Established ventures are emphasizing more on collaboration to develop plant-based expression technology and manufacturing plant facilities in economies like UK, Germany and the Netherlands; this is projected to drive the European plant-based biologics market growth. Furthermore, increasing technological advancements, rising adoption of cutting-edge innovative techniques, and high investments in RD departments are some of the key factors driving the plant-based biologics market in the Europe market. North-America plant-based biologics market is projected to grow at a CAGR of 6.2% by registering revenue of $87.3 million by 2026. Leading players such as iBio, Inc., have an advanced system called Fast Pharming that combines glycan engineering technologies and vertical farming for the production of high-quality plant-based monoclonal antibodies and vaccines. In addition, in Canada, the Canadian Food Inspection Agencys (CFIA) and Plant Biosafety Office (PBO)has begun plant-made biologic drugs production.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/150

The major plant-based biologics market manufacturers are Fraunhofer IME, PlantForm, Mapp Biopharmaceautical Leaf Bio., Kentucky BioProcessing, Inc., Icon Genetics GmbH, Medicago, Inc., iBio, Greenovation Biotech GmbH, Ventria Bioscience Inc., and PhycoBiologics Inc.To emphasize more on the competitive landscape analysis of established enterprises, the porters five force model is explained in the report.

Porters Five Forces Analysis for Plant-based biologics market:

Bargaining Power of Suppliers: Established suppliers in the healthcare industry use their negotiating power to extract high prices. Moreover, the switching costs from one supplier to another supplier is projected to be high.
The bargaining power of suppliers is HIGH.

Bargaining Power of Buyer: Hospitals and other healthcare institutions buy plant-based biologics in bulk quantities and apply pressure on pharmaceutical ventures to keep prices in check.
The bargaining power of consumers is MEDIUM.

Threat of New Entrants: High cost associated with RD along with government regulatory constraints, provides the low threat of entry from new or potential competitors.
The threat of new entrants isLOW.

Threat of Substitutes: The threat of a substitute product is high if it provides a value proposition that is significantly different from the present service of the market.
The threat of substitutes is LOW.

Competitive Rivalry in the Market: Plant-based biologics market contains numerous small, medium, and large ventures. Leading enterprises are following alternative business strategies and technological advances among them, is also a significant factor for the high competitive rivalry in the global market.
The competitive rivalry in the industry is HIGH.

Abouat Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Home

Friday, April 30, 2021

Thursday, April 29, 2021